UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

Nature medicine, 2012-12, Vol.18 (12), p.1835-1840

2012

Link zum Volltext

Verfügbarkeit prüfen

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

Proceedings of the National Academy of Sciences - PNAS, 2011-02, Vol.108 (8), p.3270-3275

2011

Link zum Volltext

Verfügbarkeit prüfen

The integrated landscape of driver genomic alterations in glioblastoma

Nature genetics, 2013-10, Vol.45 (10), p.1141-1149

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4722-4729

2010

Link zum Volltext

Verfügbarkeit prüfen

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.7843-7848

2006

Link zum Volltext

Verfügbarkeit prüfen

Mutant metabolic enzymes are at the origin of gliomas

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24), p.9157-9159

2009

Link zum Volltext

Verfügbarkeit prüfen

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Nature communications, 2021-01, Vol.12 (1), p.352-352, Article 352

2021

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4722-4729

2007

Link zum Volltext

Verfügbarkeit prüfen

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

Nature communications, 2021-03, Vol.12 (1), p.1858-1858, Article 1858

2021

Link zum Volltext

Verfügbarkeit prüfen

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Nature communications, 2018-05, Vol.9 (1), p.2087-11, Article 2087

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

Clinical cancer research, 2007-02, Vol.13 (4), p.1253-1259

2007

Link zum Volltext

Verfügbarkeit prüfen

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (1), p.270-275

2013

Link zum Volltext

Verfügbarkeit prüfen

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Oncotarget, 2014-03, Vol.5 (6), p.1515-1525

2014

Link zum Volltext

Verfügbarkeit prüfen

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

Nature communications, 2020-01, Vol.11 (1), p.524-524, Article 524

2020

Link zum Volltext

Verfügbarkeit prüfen

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Cancer cell, 2016-01, Vol.29 (1), p.49-60

2016

Link zum Volltext

Verfügbarkeit prüfen

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma

PloS one, 2014-04, Vol.9 (4), p.e94281-e94281

2014

Link zum Volltext

Verfügbarkeit prüfen

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

PloS one, 2019-01, Vol.14 (1), p.e0210608

2019

Link zum Volltext

Verfügbarkeit prüfen

Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas

Archives of pathology & laboratory medicine (1976), 2017-12, Vol.141 (12), p.1697-1704

2017

Link zum Volltext

Verfügbarkeit prüfen

Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (22), p.6097-6108

2017

Link zum Volltext

Verfügbarkeit prüfen

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

PloS one, 2011-02, Vol.6 (2), p.e16812-e16812

2011

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Treatment of Malignant Astrocytoma

Journal of clinical oncology, 2006-03, Vol.24 (8), p.1253-1265

2006

Link zum Volltext

Verfügbarkeit prüfen

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways

The Journal of clinical investigation, 2014-10, Vol.124 (10), p.4489-4502

2014

Link zum Volltext

Verfügbarkeit prüfen

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Molecular cancer therapeutics, 2009-10, Vol.8 (10), p.2773-2779

2009

Link zum Volltext

Verfügbarkeit prüfen

Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (2), p.496-501

2013

Link zum Volltext

Verfügbarkeit prüfen

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

Clinical cancer research, 2006-09, Vol.12 (17), p.5064-5073

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 715

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(681)
Mit Volltextzugriff
(666)

Publikationsform

Artikel
(712)
Buchkapitel
(3)

Sprache

Englisch
(715)
Japanisch
(96)

Erscheinungsjahr

n.n

Thema

Science & Technology
(434)
Humans
(404)
Life Sciences & Biomedicine
(399)
Animals
(284)
Oncology
(261)
Biological And Medical Sciences
(232)
Medical Sciences
(219)
Mice
(193)
Female
(178)
Male
(169)
Pharmacology. Drug Treatments
(116)
Neurology
(113)
Antineoplastic Agents
(108)
Tumors
(106)
Adult
(99)
Neurosciences & Neurology
(97)
Middle Aged
(94)
Mice, Nude
(91)
Tumors Of The Nervous System. Phacomatoses
(85)
Neoplasm Transplantation
(83)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

The integrated landscape of driver genomic alterations in glioblastoma

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

Mutant metabolic enzymes are at the origin of gliomas

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas

Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

Recent Advances in the Treatment of Malignant Astrocytoma

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

Suchergebnisse filtern